(Continued from page 37)

also require the agency to coordinate its oversight of compounded-drug safety with states.
• Compounders could voluntarily register as outsourcing facilities, which would bring them under FDA authority. Registering will let the agency identify who these companies are and what they produce, and allow the FDA to receive reports about any problems.

(Continued on page 39)